Nuclear VCP-Like (NVL) (Middle Region) Peptid
NVL
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle NVL Produkte
- NVL (Nuclear VCP-Like (NVL))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- ARVLVIGATN RPDSLDPALR RAGRFDREIC LGIPDEASRE RILQTLCRKL
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- NVL Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- NVL (Nuclear VCP-Like (NVL))
- Hintergrund
-
This gene encodes a member of the AAA (ATPases associated with diverse cellular activities) superfamily. Multiple transcript variants encoding different isoforms have been found for this gene. Two encoded proteins, described as major and minor isoforms, have been localized to distinct regions of the nucleus. The largest encoded protein (major isoform) has been localized to the nucleolus and shown to participate in ribosome biosynthesis (PMID: 15469983, 16782053), while the minor isoform has been localized to the nucleoplasmin.
Protein Size: 765 - Gen-ID
- 4931
- NCBI Accession
- NM_001243146, NP_001230075
-
Sie sind hier:
